Volant, a Chinese developer of electric vertical take-off and landing aircraft (eVTOLs), has closed its third funding round this year while Chengwei Capital co-led a $20-million seed round in Tesseract Medicines.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
